FDA Adverse Event Summary report: N

STATSEAL DISC

MDR report key: 6250839 · Received January 13, 2017

Report

Report Number
1066421-2017-00001
Date Received
January 13, 2017
Date of Event
December 1, 2016
Report Date
January 31, 2017
Manufacturer
BIOLIFE, LLC
Product Code
FRO
PMA / PMN Number
K130324
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SINGLE USE DEVICE.

Additional Manufacturer Narrative · 1

EVALUATION OF BIOLIFE'S CHIEF MEDICAL ADVISOR DR. (B)(4). IN RESPONSE, THE INCIDENT WITH INVOLVING THE STATSEAL DISC AND THE NEONATE. IT APPEARS THAT A STERISTRIP WAS USED TO SECURE THE DISC. I SUSPECT THIS CREATED A SPECIFIC PRESSURE AREA THAT WITH THE TEXTURE OF THE DISC WOULD LEAD TO A SKIN BREAKDOWN. A STERISTRIP WOULD CREATE A UNIQUE POINT OF CONTACT THAT WOULD BE VERY DEFINED OVER A SMALL AREA. INCREASING THE RISK OF BREAKDOWN OR A TEAR BY CONTACT. APPLYING A MORE EVENLY DISTRIBUTED DRESSING WOULD MAKE MORE SENSE. (B)(6). SINGLE USE DEVICE.

Description of Event or Problem · 1

"A (B)(6) PATIENT IN WHICH THEY APPLIED THE STATSEAL DISC POST PICC INSERTION, AND THE PRODUCT SEEMED TO EAT AWAY AT THE SKIN. THEY FILLED OUT AN INCIDENT REPORT. THE WOUND CARE TEAM WAS CALLED IN. THE SITE HAD BRUISING. THEY DO NOT USE BIOPATCH. THEY USED CHLORHEXADINE GLUCONATE 1-2% ON PATIENTS >28 WEEKS. UNDER THIS AGE, THEY ONLY USE BETADINE AT THE INSERTION SITE".

Description of Event or Problem · 1

"A (B)(6) WEEK PATIENT IN WHICH THEY APPLIED THE STATSEAL DISC POST PICC INSERTION, AND THE PRODUCT SEEMED TO EAT AWAY AT THE SKIN. THEY FILLED OUT AN INCIDENT REPORT. THE WOUND CARE TEAM WAS CALLEDIN. THE SITE HAD BRUISING. THEY DO NOT USE BIOPATCH. THEY USED CHLORHEXADINE GLUCONATE 1-2% ON PATIENTS >28 WEEKS. UNDER THIS AGE , THEY ONLY USE BETADINE AT THE INSERTION SITE".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
34813 STATSEAL DISC STATSEAL DISC FRO BIOLIFE, LLC DT013

Patients

Seq Age Sex Outcome Treatment
1 6 MO Other